[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-351720-105":59,"doc-detail-351720-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","dna-methylation-mediated-silencing-of-hnf1b-promotes-bladder-cancer-progression","DNA methylation-mediated silencing of HNF1B promotes bladder cancer progression","","This study investigates hepatocyte nuclear factor 1 homeobox B (HNF1B), a developmentally essential transcription factor with documented tumor-suppressive roles in several cancers via epigenetic silencing. Clinical cohort analyses show that low HNF1B expression independently predicts poor prognosis and worsened clinicopathological features in bladder cancer. Functional experiments demonstrate that HNF1B knockdown enhances malignant behaviors, while overexpression suppresses proliferation, migration, invasion, and tumor growth. Promoter hypermethylation mediates silencing, with MAPK pathway inhibition and reduced epithelial–mesenchymal transition underlying the antitumor effects, suggesting biomarker potential.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/dna-methylation-mediated-silencing-of-hnf1b-promotes-bladder-cancer-progression/351720/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/dna-methylation-mediated-silencing-of-hnf1b-promotes-bladder-cancer-progression/351720.png","ImageObject",300,407,{"name":92,"@type":93},"McQueen","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-04","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":24},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What clinical relationship does HNF1B show in bladder cancer patients?","Question",{"text":112,"@type":113},"Low HNF1B expression is an independent prognostic factor linked to adverse clinicopathological characteristics and poorer survival in bladder cancer.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How does HNF1B affect bladder cancer cell behavior?",{"text":117,"@type":113},"HNF1B knockdown promotes proliferation, migration, and invasion, while HNF1B overexpression suppresses these malignant phenotypes in vitro and reduces tumor growth in vivo.",{"name":119,"@type":110,"acceptedAnswer":120},"What mechanism silences HNF1B and through which pathways does it act?",{"text":121,"@type":113},"HNF1B silencing is primarily mediated by promoter hypermethylation. HNF1B exerts tumor-suppressive roles by inhibiting the MAPK signaling pathway and the epithelial–mesenchymal transition (EMT) process.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},351720,1790172934,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":24,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},5909890329169,"https://ap-avatar.wpscdn.com/davatar_9964176cb1d06d4a9deccf72a44ae3dc","Luo et al. Clinical Epigenetics (2026) 18:91 [https://doi.org/10.1186/s13148-026-02079-z](https://doi.org/10.1186/s13148-026-02079-z)  \nClinical Epigenetics  \nRESEARCH Open Access  \nDNA methylation-mediated silencing of HNF1B promotes bladder cancer progression  \nCong Luo1†, Xiaogen Kuang2,3†, Yuanqing Dai2, Zhiyong Cai2, Jiao Hu2, Ping Liu4* and Jinbo Chen2,5*  \nAbstract  \nBackground Hepatocyte nuclear factor 1 homeobox B (HNF1B), a developmentally crucial transcription factor, demonstrates tumor-suppressive functions in several cancers, with epigenetic silencing being a known mechanism, as seen in malignancies like ovarian and prostate carcinoma. Its functional significance in bladder cancer pathogenesis is far less clear.  \nResults Our analysis of clinical cohorts identified low HNF1B expression as an independent prognostic factor that is significantly associated with adverse clinicopathological characteristics and poorer survival in bladder cancer patients. Functionally, knockdown of HNF1B promoted bladder cancer cell proliferation, migration, and invasion, whereas its overexpression suppressed these malignant phenotypes in vitro and attenuated tumor growth in  \nvivo. Mechanistically, HNF1B silencing was primarily mediated by promoter hypermethylation. Furthermore, we demonstrated that HNF1B exerts its tumor-suppressive roles by concurrently inhibiting the mitogen-activated protein kinase (MAPK) signaling pathway and the epithelial–mesenchymal transition (EMT) process.  \nConclusion Our study unveils a novel epigenetic mechanism in bladder cancer, whereby promoter hypermethylation silences HNF1B, thereby promoting tumor progression through activation of the MAPK pathway. These findings establishe HNF1B status as a potential biomarker for stratifying patients who may benefit from targeted therapies against this pathway.  \nKeywords HNF1B, DNA methylation, Bladder cancer, MAPK pathway  \n†Cong Luo and Xiaogen Kuang contributed equally to this work.  \n*Correspondence:  \nPing Liu [liuping@hnca.org.cn](liuping@hnca.org.cn)[ ](liuping@hnca.org.cn)Jinbo Chen[chenjinbo@csu.edu.cn](chenjinbo@csu.edu.cn)  \n1Department of Anesthesiology, Xiangya Hospital, Central South University, Changsha, China  \n2Department of Urology, Xiangya Hospital, Central South University, Changsha, China  \n3Department of Urology, The First Affiliated Hospital, Hengyang Medical School, University of South China, Hengyang, Hunan, China 4Department of Radiation Oncology and Hunan Key Laboratory of Translational Radiation Oncology, The Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University/Hunan Cancer Hospital, Changsha, China  \n5National Clinical Research Center for Geriatric Disorders, Xiangya Hospital, Central South University, Changsha, China  \n© The Author(s) 2026. Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit [http://creativecommons.org/licenses/by/4.0/](http://creativecommons.org/licenses/by/4.0/.)[.](http://creativecommons.org/licenses/by/4.0/.)  \nLuo et al. Clinical Epigenetics (2026) 18:91  \nBackground  \nBladder cancer (BLCA) is a prevalent genitourinary malignancy with a rising incidence rate [1]. A significant proportion of patients present with muscle-invasive disease, known fo","cbCaikhVKP2rU16g","https://ap.wps.com/l/cbCaikhVKP2rU16g","pdf",2652480,13,"English","# Background\n# Results\n# Conclusion","[{\"question\":\"What clinical relationship does HNF1B show in bladder cancer patients?\",\"answer\":\"Low HNF1B expression is an independent prognostic factor linked to adverse clinicopathological characteristics and poorer survival in bladder cancer.\"},{\"question\":\"How does HNF1B affect bladder cancer cell behavior?\",\"answer\":\"HNF1B knockdown promotes proliferation, migration, and invasion, while HNF1B overexpression suppresses these malignant phenotypes in vitro and reduces tumor growth in vivo.\"},{\"question\":\"What mechanism silences HNF1B and through which pathways does it act?\",\"answer\":\"HNF1B silencing is primarily mediated by promoter hypermethylation. HNF1B exerts tumor-suppressive roles by inhibiting the MAPK signaling pathway and the epithelial–mesenchymal transition (EMT) process.\"}]","DNA methylation-mediated silencing of HNF1B promotes bladder cancer progression | PDF",1790095517,33,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/e27ef5c781360aa8fc8e1224ba99b556.webp",983,1310,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/d6ee812dbef336768cfd13a5c29e35b1.webp",982,1309,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/04f93a70dce87c6ce1781e79a0bdf6e5.webp",981,1308,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/07eb5b2a7ce65ab5cc3010eea0ff2def.webp",980,1306]